Roland Andersson
81 – 90 of 365
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Histone profiling reveals the H1.3 histone variant as a prognostic biomarker for pancreatic ductal adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Impact of body constitution on complications following pancreaticoduodenectomy : A retrospective cohort study
(
- Contribution to journal › Article
-
Mark
Development and In Vitro Characterization of a Gemcitabine-loaded MUC4-targeted Immunoliposome Against Pancreatic Ductal Adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Outcome and evaluation of prognostic factors after pancreaticoduodenectomy for distal cholangiocarcinoma
(
- Contribution to journal › Article
-
Mark
The role of irreversible electroporation (IRE) for locally advanced pancreatic cancer : a systematic review of safety and efficacy
(
- Contribution to journal › Scientific review
-
Mark
Biomarkers, imaging and multifocality in intraductal papillary mucinous neoplasms : Relevant for decision making?
(
- Contribution to journal › Scientific review
-
Mark
Does next-generation sequencing of cyst fluid improve management of pancreatic cystic neoplasms?
(
- Contribution to journal › Scientific review
-
Mark
The challenges of centralization with HPB resectional surgery
(
- Contribution to journal › Letter
-
Mark
Pancreatic ductal adenocarcinoma : Is a cure possible?
(
- Contribution to journal › Scientific review
-
Mark
Low MUC4 expression is associated with survival benefit in patients with resectable pancreatic cancer receiving adjuvant gemcitabine
(
- Contribution to journal › Article